High pSTAT3 TSPhigh cases demonstrated enrichment for reduced MHC-1 presentation coupled with reduced CD8 + cells within the tumor microenvironment highlighting impaired anti-tumor immunity. This evidence concerns the gene CD8A and neoplasm.